Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × Radiotherapy, Intensity-Modulated × Clear all

Phase

Status

Completed 20 Terminated 9 Active not recruiting 5 Unknown 4 Withdrawn 2 Recruiting 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Radiotherapy 2 Lenalidomide 2 Carboplatin 2 tislelizumab 1 irinotecan sucrosofate 1 enzalutamide 1 Ruthenium-106 1 Radiotherapy, Intensity-Modulated 1 Paclitaxel 1 Melphalan 1 Mannitol 1 Leukocyte Count 1 Irinotecan 1 Folfox protocol 1 Dexamethasone 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06890871 2025-03-24

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Zhongnan Hospital

Phase 1/2 Enrolling by invitation

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡